Abstract:Abstract Background: Hepatocellular carcinoma (HCC) is the most common form of liver cancer and accounts for ∼90% of cases globally. Detection of early-stage HCC is vital as it allows for potentially curative treatment, yet remains a significant challenge. Micronuclei (MN) are a hallmark of genomic instability. An increased frequency of MN is commonly observed in tumor cells as well as other somatic cells, including erythrocytes, in cancer patients. Here, we have established a technique (WO2021/228246 A1), for the isolation and analysis of micronuclei DNA (MN-DNA) in erythrocytes from peripheral blood. Significant changes in read densities at specific genomic locations within MN-DNA were identified in patients, termed as tumor- associated MN-DNA (taMN-DNA) features. This study evaluates the potential of these taMN- DNA features for early-stage HCC detection across human and murine model. Methods: To explore the potential of MN-DNA in cancer detection, we first collected 1-2 mL of whole blood from HDs (N = 53) and HCC patients (N = 53). MN-DNA was isolated and purified from erythrocytes, followed by whole-genome sequencing. Participants were randomly divided into training, test cohorts in an 8:2 ratio. We applied machine learning algorithms to leverage these features for cancer detection in the human model. Additionally, to investigate the formation of taMN-DNA features, we employed a well-established mouse model that mimics HCC development. Mice were injected with the genotoxic agent diethylnitrosamine (DEN) 2 weeks after birth, and developed malignant macroscopic liver nodules at approximately 40 weeks of age. Results: In the human cohort, we enrolled 106 participants, with more than half of the HCC cases were diagnosed at early-stage (stage 0-II). The cancer detection model utilizing taMN- DNA features achieved an overall accuracy of 86.3%, with a sensitivity of 81.8% and specificity of 90.9%. For early-stage, the model demonstrated sensitivities of 54.5% at a specificity of 90.9%. In the DEN-induced HCC mouse model, unsupervised hierarchical clustering based on these selected taMN-DNA features clearly separated WT and tumor mice into two distinct groups. Notably, mice that were not tumorigenic at 36 weeks post-treatment in the DEN-treated group fell into the WT group when classified by the same taMN-DNA features, indicating that the formation of taMN-DNA signatures is associated with the presence of tumors specifically. Conclusions: This pilot study highlights the potential of MN-DNA as a promising tool for early HCC detection. Leveraging these taMN-DNA features can accurately distinguish early-stage HCC patients from HDs with high sensitivity. In both human and murine models, there is a significant relationship between these signatures and tumor presence, suggesting that taMN- DNA features might reflect the diseased state across mammalian species. Research sponsor: Timing Biotech. Citation Format: Hui Lin, Haobo Sun, Xingyun Yao, Xiaoxiao Fan, Fei Meng, Honghao Liang, Xiaofei Gao. Leveraging micronuclei DNA from erythrocytes for early detection of hepatocellular carcinoma [abstract]. In: Proceedings of the AACR Special Conference: Liquid Biopsy: From Discovery to Clinical Implementation; 2024 Nov 13-16; San Diego, CA. Philadelphia (PA): AACR; Clin Cancer Res 2024;30(21_Suppl):Abstract nr B073.

Mature Red Blood Cells Contain Long DNA Fragments and Could Acquire DNA from Lung Cancer Tissue

New Role of Red Blood Cells in Absorption of DNA Bearing Tumorigenic Mutations from Lung Cancer Tissue

New Insights into Red Blood Cells in Tumor Precision Diagnosis and Treatment

Abstract B073: Leveraging Micronuclei DNA from Erythrocytes for Early Detection of Hepatocellular Carcinoma

Red Blood Cell-Derived Exosomal Oncogenic MicroRNA Promote Cancer Development and Progression

Use of micronuclei DNA from erythrocytes in early-stage colorectal cancer detection.

Uptake of DNA by cancer cells without a transfection reagent

Ribosomal DNA Copy Number Alteration in Blood Sample from Gastric Cancer Patients.

Cell-free DNA end characteristics enable accurate and sensitive cancer diagnosis

Abstract A041: Detection of Early-Stage Gastrointestinal Cancers Using Micronuclei DNA from Erythrocytes

Abstract A045: Evaluating the Potential of Micronuclei DNA from Erythrocytes for Early Detection of Colorectal Cancer

Evaluating the Potential of Micronuclei DNA from Erythrocytes for Early Detection or Recurrence Risk Prediction of Colorectal Cancer.

Distinct Features of Plasma Ultrashort Single-Stranded Cell-Free DNA as Biomarkers for Lung Cancer Detection

RARβ2 gene methylation level in the circulating DNA from blood of patients with lung cancer

Extracellular Vesicles Long RNA Sequencing Reveals Abundant Mrna, Circrna, and Lncrna in Human Blood As Potential Biomarkers for Cancer Diagnosis.

The distribution of the extrachromosomal DNA molecules in early lung cancer

Evaluating methylation of human ribosomal DNA at each CpG site reveals its utility for cancer detection using cell-free DNA

Plasma cell-free DNA fragmentation patterns combined with tumor mutation detection in diagnosis of lung cancer

The Mtdna Fragments Within Exosomes Might Be Novel Diagnostic Biomarkers of Non-Small Cell Lung Cancer.

Detection of early-stage gastrointestinal cancers by micronuclei DNA from erythrocytes.

Fragment Enrichment Of Circulating Tumor Dna With Low-Frequency Mutations